Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.11 (
AMPK
)
12,425
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of forskolin on the regulation of steroidogenesis and growth were examined in the Y1 adrenocortical tumor cell line, and the roles of cAMP and
cAMP-dependent protein kinase
in these actions of forskolin were evaluated.
Forskolin
, like corticotropin, stimulated steroidogenesis 3-fold and inhibited growth by 90%. In mutants of the Y1 cell line harboring specific defects in
cAMP-dependent protein kinase
activity, the responses to forskolin were attenuated. The resistance of the protein kinase mutants to the diterpene was closely correlated with their resistance to corticotropin and with impaired responses of their protein kinases to cAMP. These results indicate that cAMP and
cAMP-dependent protein kinase
are obligatory components of forskolin's actions on Y1 adrenal cells.
Forskolin
, at concentrations which were approximately 100-times greater than those required to stimulate steroidogenesis, caused cAMP to accumulate. Apparently, only a small fraction of the cAMP generated in response to forskolin was required to stimulate steroidogenesis or inhibit growth.
...
PMID:The roles of cAMP and cAMP-dependent protein kinase in forskolin's actions on Y1 adrenocortical tumor cells. 300 70
Forskolin
, a diterpene extracted from Coleus forskolii, stimulates the production of cAMP in a variety of cells and is potentially an important tool for studying the role of cAMP in the modulation of neuronal excitability. We studied the effects of forskolin on neurons of nudibranch molluscs and found that it caused characteristic, reversible changes in the amplitude and waveform of the transient K current, IA, and also activated an inward current similar to the cAMP-dependent inward current previously described in molluscan neurons.
Forskolin
altered the time course of IA activation and inactivation but did not affect the voltage dependence or the reversal potential of the current. IA normally inactivates exponentially, but in forskolin the time course of inactivation can be fit by the sum of 2 exponentials with an initial rate that is faster than the control and a final rate that is much slower. On depolarization in forskolin, IA begins to activate at the normal rate, but a slower component of activation is also seen. The changes in IA in the nudibranch cells were qualitatively different than the changes caused by forskolin in Aplysia bag cell neurons (Strong, 1984). Experiments were performed to determine whether these effects of forskolin require cAMP. Intracellular injection of cAMP, application of membrane-permeable analogs of cAMP, application of phosphodiesterase inhibitors, and intracellular injection of the active catalytic subunit of
cAMP-dependent protein kinase
did not affect the amplitude or waveform of IA. Also, the changes in IA that are caused by forskolin were not prevented or reversed by intracellular injection of an inhibitor of
cAMP-dependent protein kinase
. Cyclic AMP did, however, activate inward current at voltages near the resting potential. We conclude that the changes in IA and the activation of inward current represent separate affects of forskolin. The inward current appears to depend on an increase in intracellular cAMP, while the changes in IA do not. These experiments show that, in addition to activating adenylate cyclase, forskolin may have a separate direct affect on the transient K current.
...
PMID:Forskolin's effect on transient K current in nudibranch neurons is not reproduced by cAMP. 302 41
Treatment of isolated rat adipocytes with epinephrine or isoproterenol caused a time- and concentration-dependent increase in phospholipid methyltransferase (PLMT) activity that was blocked by propranolol and unaffected by phentolamine.
Forskolin
mimicked the stimulatory effect on PLMT, and insulin inhibited this effect. In both the absence and presence of insulin, there was a linear relationship between PLMT activity and lipolysis. PLMT activity was also increased in response to oxytocin, which does not activate adenylate cyclase in adipocytes and does not stimulate lipolysis. The effects of oxytocin were inhibited by insulin and were additive with those of isoproterenol on PLMT. These data support the hypothesis that in adipocytes, PLMT is activated by a
cAMP-dependent protein kinase
and a cAMP-independent mechanism, both of which can be regulated independently, and both of which are sensitive to inhibition by insulin.
...
PMID:Hormonal regulation of phospholipid methyltransferase by 3',5'-cyclic adenosine monophosphate-dependent and independent mechanisms. 303 90
The effects of forskolin on phosphorylation of proteins of a 100,000 X g fraction was examined in isolated beating guinea pig hearts. Hearts were perfused with [32P] inorganic phosphate to label intracellular adenine nucleotides.
Forskolin
was injected into the coronary circulation and after freeze-clamping, phosphorylated proteins in a fraction were separated by sodium dodecyl sulfate-polyacrylamide gel electro-phoresis.
Forskolin
increased the incorporation into a 25,000 Mr protein approximately 15 fold over control. Incorporation of label was time and dose dependent and was temporally coincident with increases in developed tension. A sarcolemmal fraction prepared from perfused hearts contained a similar 25,000 Mr protein. The data provides evidence that forskolin induced inotropy is accompanied by
cAMP-dependent protein kinase
mediated phosphorylation. The phosphorylation may be of the same protein whose phosphorylation is associated with epinephrine-induced increase in contractility.
...
PMID:Effect of forskolin on phosphorylation of a 25,000 Mr protein in perfused guinea pig hearts. 404 May 33
Forskolin
(FOR), a diterpene activator of adenylate cyclase, produced time- and dose-dependent increases in cAMP,
cAMP-dependent protein kinase
activation and relaxation in the contracted rat aorta but had no effect on cGMP levels. Nitroprusside (NP) increased cGMP levels and relaxation but had no effect on cAMP levels.
cAMP-dependent protein kinase
activation was seen with higher concentrations of NP. Major differences were observed in the modes of action of the two compounds: (1) the time course of relaxation to FOR was slower than that to NP (15 min vs. 3 min) even though the
cAMP-dependent protein kinase
activity ratio was maximally elevated at 3 min after the addition of FOR; (2) FOR and dibutyryl cAMP prevented contraction to both norepinephrine (NE) and KCl whereas NP and 8-bromo-guanosine 3',5'-monophosphate (8-Br-cGMP) were more effective in preventing contraction to NE than to KCl. In addition, the analog of cGMP was more effective in preventing contraction to KCl at lower concentrations of external Ca2+ while the analog of cAMP prevented contraction to KCl at all concentrations of Ca2+ equally. Nevertheless, some similarities in the actions of FOR and NP were apparent in that both agents relaxed the NE-contracted aorta more effectively than the KCl-contracted aorta, and both agents relaxed aorta contracted with lower doses of NE more effectively than that contracted with high doses of NE. These results suggest that although some similarities in the relaxing action of rat aorta by FOR and NP exist, major differences are apparent which suggests that the two compounds exert these effects through unique biochemical mechanisms.
...
PMID:A comparison of the effects of forskolin and nitroprusside on cyclic nucleotides and relaxation in the rat aorta. 608 62
Forskolin
(40 microM) stimulated adenylate cyclase activities of bovine thyroid plasma membranes without the addition of guanine nucleotides. GDP had little effect on the forskolin-stimulated adenylate cyclase activity while Gpp[NH]p (0.1-1.0 microM) decreased it. In the presence of TSH (10 mU/0.11), Gpp[NH]p no longer caused inhibition.
Forskolin
did not affect phosphodiesterase activities of thyroid homogenates.
Forskolin
(10 microM) rapidly increased cAMP levels in bovine thyroid slices both in the absence and presence of a phosphodiesterase inhibitor. The effect of TSH (50 mU/ml) on cAMP levels was additive or greater than additive to that of forskolin. An initial 2-h incubation of slices with forskolin did not decrease their subsequent cAMP responses to either forskolin and/or TSH while similar treatment of slices with TSH induced desensitization of the cAMP response to TSH, but not to forskolin.
Forskolin
(10 microM) as well as TSH (50 mU/ml) activated
cAMP-dependent protein kinase
of slices in the absence of a phosphodiesterase inhibitor. Although forskolin activated the adenylate cyclase cAMP system, it did not stimulate iodide organification or glucose oxidation, effects which have been attributed to cAMP. In fact, forskolin inhibited these parameters and 32P incorporation into phospholipids as well as their stimulation by TSH. These results indicate that an increase in cAMP levels and
cAMP-dependent protein kinase
activity in thyroid slices may not necessarily reproduce the effects of TSH on the thyroid.
...
PMID:Effects of forskolin on adenylate cyclase, cyclic AMP, protein kinase and intermediary metabolism of the thyroid gland. 629 78
Forskolin
, a specific diterpene activator of adenylate cyclase in intact cells and cellular homogenates, was used to examine the relationship among adenosine 3',5'-cyclic monophosphate (cAMP) metabolism, gastric acid, and pepsinogen secretion in isolated gastric glands. This agent was found to stimulate [14C]aminopyrine (AP) accumulation and respiration, both measurements of which are indexes of parietal cell acid secretory responsiveness and pepsinogen secretion, which is a measure of chief cell activity.
Forskolin
also increased cAMP content and activated
cAMP-dependent protein kinase
in the glands. The histamine H2-receptor antagonist, cimetidine, inhibited forskolin-stimulated increases in AP accumulation and respiration when submaximal concentrations of forskolin were used but had not effect on the other response parameters.
Forskolin
also potentiated the action of the muscarinic agonist, carbachol, in both the presence and absence of cimetidine. Since there was a close kinetic and temporal correlation between the secretory response parameters and
cAMP-dependent protein kinase
activation, it appears that cAMP plays an important role in the mediation of gastric acid and pepsinogen secretion. The inhibitory action of cimetidine on forskolin-stimulated AP accumulation and respiration suggest that forskolin potentiates the action of endogenous histamine present in the glands.
Forskolin
potentiation of carbachol in the presence of maximum inhibitory concentrations of cimetidine indicates that previously observed potentiating interactions between carbachol and histamine, secretagogues which appear to act via cAMP-independent and cAMP-dependent mechanisms, respectively, involve intracellular events that occur subsequent to the binding of these agents to their respective receptors and subsequent to an increase in intracellular cAMP content.
...
PMID:Forskolin stimulation of acid and pepsinogen secretion in isolated gastric glands. 631 18
Forskolin
is a positive inotropic-acting and blood pressure lowering agent which was isolated from the Indian plant Coleus forskohlii. In isolated heart tissue, forskolin activates a membrane bound adenylatecyclase and a cytoplasmic
cAMP-dependent protein kinase
to a much higher degree than does isoprenaline. This activation does not require the hormone receptor. In isolated and electrically stimulated left guinea pig atria, the adenylate-cyclase activation by forskolin is the prerequisite for the positive inotropic effect. We therefore postulate the adenylatecyclase activation to be correlated with the positive inotropic effect via an enhanced calcium uptake by the heart muscle cell.
...
PMID:The positive inotropic-acting forskolin, a potent adenylate cyclase activator. 719 29
Activation of the mitogen-activated protein kinase (MAP kinase) isoforms ERK1 and ERK2 was investigated in rat adipocytes. Kinase activities were measured by using myelin basic protein as substrate after the isoforms were resolved by Mono Q chromatography or by immunoprecipitation with specific antibodies. Insulin increased the activity of both isoforms by 3- to 4-fold. The beta-adrenergic agonist isoproterenol was without effect in the absence of insulin but markedly reduced the increases in ERK1 and ERK2 activities produced by the hormone. MAP kinase activation was also attenuated by forskolin and glucagon, which increase intracellular cAMP, and by dibutyryl-cAMP, 8-bromo-cAMP, and 8-(4-chlorophenylthio)-cAMP. Thus, increasing cAMP is associated with decreased activation of MAP kinase by insulin.
Forskolin
also inhibited activation of MAP kinase by several agents (epidermal growth factor, phorbol 12-myristate 13-acetate, and okadaic acid) that act independently of insulin receptors. Moreover, forskolin did not inhibit insulin-stimulated tyrosine phosphorylation of the insulin receptor substrate IRS-1. Therefore, the inhibitory effect on MAP kinase did not result from compromised functioning of the insulin receptor. The inhibitory effect was not confined to adipocytes, as forskolin and dibutyryl-cAMP inhibited the increase in MAP kinase activity by phorbol 12-myristate 13-acetate in wild-type CHO cells. In contrast, these agents did not inhibit MAP kinase activity in mutant CHO cells (line 10248) that express a
cAMP-dependent protein kinase
resistant to activation by cAMP. Our results suggest that activation of
cAMP-dependent protein kinase
represents a general counter-regulatory mechanism for opposing MAP kinase activation.
...
PMID:Increasing cAMP attenuates activation of mitogen-activated protein kinase. 769 90
Activation of muscarinic receptors has been shown to inhibit L-type calcium conductances by mechanisms sensitive to pertussis toxin (PTX). In this study we show that agonist stimulation of the m4 muscarinic receptor leads to an increase in an L-type calcium conductance in the AtT-20 pituitary cell line, by a PTX-sensitive mechanism. The amplitude of the dihydropyridine (DHP)-sensitive or L-type calcium current was increased by acetylcholine (ACh), with no shift in the voltage dependence. This action of ACh was completely inhibited by PTX pre-treatment.
Forskolin
, cAMP and phorbol 12,13-dibutyrate reduced, while RpcAMPs, an inhibitor of
cAMP-dependent protein kinase
(PKA), increased the L-type calcium conductance. We propose that the m4 muscarinic receptor activates the L-type calcium channel by inhibition of adenylyl cyclase resulting in reduced cAMP levels and, hence, reduced PKA activity. This novel increase in calcium current via the m4 muscarinic receptor appears to reflect the coupling with an L-type channel of the D class, due to the sensitivity of the L-type calcium conductance to both DHPs and omega-conotoxin, and, thus, is distinct from the skeletal muscle and cardiac L-type channels of the C class previously studied.
...
PMID:Enhancement of an L-type calcium current in AtT-20 cells; a novel effect of the m4 muscarinic receptor. 779 45
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>